Moreover, increased expression of TGR5 in the liver inhibits activation of the NLRP3 inflammasome and cleavage of caspase-1, thus alleviating inflammation and contributing to the improvement in NASH [93]. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.